The funding will be used to advance the clinical development of SpliceBio’s lead gene therapy candidate, SB-007 for Stargardt disease, including the ongoing interventional Phase 1/2 ASTRA study and ...
Read more
It has been identified 24 neopeptides that could be good targets for designing preventive cancer vaccines in people with Lynch syndrome. The results show that the selected peptides are repeated among ...
Read more
The research, published in The FEBS Journal, improves understanding of classical homocystinuria, a hereditary metabolic disorder, and proposes new potential therapeutic approaches.
Read more
A team of bioinformatics specialists from IDIBELL-ICO have identified ClinCNV and GATK-gCNV as the two most accurate current bioinformatics tools in the detection of a certain type of variants related...
Read more
Oryzon Genomics, a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (...
Read more
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mutations associated with Lynch syndrome influence t...
Read more
IMPaCT-GENóMICA realiza la secuenciación del genoma completo a las personas que acceden al programa tras no haber obtenido el diagnóstico con las pruebas asistenciales habituales. Con herramientas ...
Read more
The results, recently published, provide a practical guide for forensic doctors and cardiologists to determine when post-mortem genetic testing is most appropriate.
Read more
It has been identified a biological target for combating spinal muscular atrophy: acid sphingomyelinase (ASM), an enzyme involved in the metabolism of lipids in the nervous system. Blocking its activi...
Read more
Un estudio multicéntrico ha demostrado que las personas con síndrome de Lynch presentan un riesgo significativamente mayor de desarrollar cáncer de páncreas y colangiocarcinoma (cáncer de las ví...
Read more
Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients with SCD
Read more
En sus estudios, publicados en la revista científica Heart Rhythm, presenta la métrica Vector Field Heterogeneity (VFH), presentan un nuevo indicador diseñado para cuantificar las heterogeneidades ...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
